Serena Williams is returning to tennis — and bringing the GLP-1 debate with her

Serena Williams appears to be making a return to professional tennis, reigniting public discussion around GLP-1 weight-loss medications and their use by athletes. The story raises questions about whether Williams has used or is associated with GLP-1 drugs as part of her comeback preparation. Her return is drawing significant attention both for her on-court prospects and the broader conversation about these medications in professional sports.